Markets.com Logo
markets.com

AIMBU

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    18.2245$
  • Previous Close
    18.2245$
  • 52 Week Change
    9.39$
  • Day Range
    0.00$
  • 52 Week High/Low
    10.01$ - 19.4$
  • Dividend Per Share
    --
  • Market cap
    0$
  • EPS
    --
  • Beta
    -0.237
  • Volume
    --

About

AIMBU.US is a CUSIP for the AIM Ultra Short Bond ETF. It is an exchange-traded fund (ETF) that invests primarily in U.S. dollar-denominated investment-grade fixed-income securities with an average portfolio duration of one year or less. The fund seeks to provide current income while maintaining liquidity and preserving capital.
markets.com
XRP Price Forecast 2026, 2027-2030: Can Record Cumulative ETF Inflows Push XRP Back Above $1.70?

XRP Price Forecast 2026, 2027-2030: Can Record Cumulative ETF Inflows Push XRP Back Above $1.70?

Julian Parker|--
NVDA Stock Forecast: Is $300 Within Reach After Record Q2 Earnings?

NVDA Stock Forecast: Is $300 Within Reach After Record Q2 Earnings?

Julian Parker|--
Hyperliquid HYPE Price Prediction 2026, 2027 & 2030: Can HYPE Break $100?

Hyperliquid HYPE Price Prediction 2026, 2027 & 2030: Can HYPE Break $100?

Daniel Carter|--
Dogecoin Price Forecast 2026–2030: Can DOGE Reach $1?

Dogecoin Price Forecast 2026–2030: Can DOGE Reach $1?

Julian Parker|--
Solana Price Prediction 2026, 2030 & 2040: How High Can SOL Go?

Solana Price Prediction 2026, 2030 & 2040: How High Can SOL Go?

Daniel Carter|--
Nvidia Q2 Earnings Preview: Can $92 Billion Revenue End NVDA’s Seven-Day Slide?

Nvidia Q2 Earnings Preview: Can $92 Billion Revenue End NVDA’s Seven-Day Slide?

Julian Parker|--
Ethereum (ETH) Price Prediction 2026-2030: Can ETH Break $3,000 After a 33% Weekly Rally?

Ethereum (ETH) Price Prediction 2026-2030: Can ETH Break $3,000 After a 33% Weekly Rally?

Julian Parker|--

Factors

Company Performance: AIM ImmunoTech's success in clinical trials for its drug Ampligen directly impacts the stock price.

Market Sentiment: Overall investor confidence and risk appetite affect demand for biotech stocks like AIMBU.US.

Regulatory Approvals: FDA decisions on Ampligen's approval are major price catalysts.

Competition: Competing therapies in the same disease areas influence AIMBU.US value.

Financial Health: AIM ImmunoTech's cash reserves, debt levels, and burn rate affect investor perception.

Partnerships: Collaborations with other companies can positively impact AIMBU.US stock.

People Also Watch

Latest news

CrowdStrike Stock Surges Over 10% After Record Q2 Earnings Beat

CrowdStrike Stock Surges Over 10% After Record Q2 Earnings Beat

Julian Parker|--
NVIDIA Earnings: Revenue Doubles to $96.2 Billion as FY2028 Outlook Drives Stock Reversal

NVIDIA Earnings: Revenue Doubles to $96.2 Billion as FY2028 Outlook Drives Stock Reversal

Julian Parker|--
Gold Price Today, August 27: XAU/USD Rebounds Above $4,620 as Fed Focus Returns

Gold Price Today, August 27: XAU/USD Rebounds Above $4,620 as Fed Focus Returns

Julian Parker|--

Latest Education Articles

Top Meme Coins to Watch in 2026: A Trader’s Guide

Top Meme Coins to Watch in 2026: A Trader’s Guide

Julian Parker|--
XAU/USD Trading Hours in Dubai: When Does the Gold Market Open?

XAU/USD Trading Hours in Dubai: When Does the Gold Market Open?

Daniel Carter|--
How to Trade Gold CFDs: A Beginner’s Guide to XAU/USD Trading

How to Trade Gold CFDs: A Beginner’s Guide to XAU/USD Trading

Daniel Carter|--
Recommended Topics
markets.com